Experts are rapidly focused on retatrutide, a innovative drug created by Eli Lilly, as a significant step in weight loss . Different than many previous approaches, retatrutide is a double -action compound targeting simultaneously GLP-1 and GIP, chemicals that impact hunger and glucose regulation .